X-101356060-G-C
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000061.3(BTK):c.1558C>G(p.Arg520Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R520Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000061.3 missense
Scores
Clinical Significance
Conservation
Publications
- Bruton-type agammaglobulinemiaInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, ClinGen
- isolated growth hormone deficiency type IIIInheritance: XL Classification: STRONG, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000061.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BTK | NM_000061.3 | MANE Select | c.1558C>G | p.Arg520Gly | missense | Exon 15 of 19 | NP_000052.1 | ||
| BTK | NM_001287344.2 | c.1660C>G | p.Arg554Gly | missense | Exon 15 of 19 | NP_001274273.1 | |||
| BTK | NM_001287345.2 | c.1039-1366C>G | intron | N/A | NP_001274274.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BTK | ENST00000308731.8 | TSL:1 MANE Select | c.1558C>G | p.Arg520Gly | missense | Exon 15 of 19 | ENSP00000308176.8 | ||
| BTK | ENST00000621635.4 | TSL:1 | c.1660C>G | p.Arg554Gly | missense | Exon 15 of 19 | ENSP00000483570.1 | ||
| BTK | ENST00000695614.1 | c.1558C>G | p.Arg520Gly | missense | Exon 15 of 19 | ENSP00000512053.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
X-linked agammaglobulinemia with growth hormone deficiency Pathogenic:1
This sequence change replaces arginine with glycine at codon 520 of the BTK protein (p.Arg520Gly). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and glycine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in an individual affected with X-linked agammaglobulinemia (PMID: 12655572). This variant is also known as c.1690C>G in the literature. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. A different missense substitution at this codon (p.Arg520Gln) has been determined to be pathogenic (PMID: 12655572, 7849721, 11472359, 7880320, 12217331, 15661032, 18677443, 27980540). This suggests that the arginine residue is critical for BTK protein function and that other missense substitutions at this position may also be pathogenic. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at